ArrowBiome Pte. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ArrowBiome Pte. Ltd. - overview
Established
2022
Location
Singapore, -, Singapore
Primary Industry
Biotechnology
About
Founded in 2022 by co-founders Boon Chong Goh and Maurice van Steensel and based in Singapore, ArrowBiome is developing solutions for the human microbiome that revolutionize microbiome care through their innovative approach. In June 2024, ArrowBiome Pte. Ltd. raised USD 1 million in seed funding from investors Cocoon Capital.
The company's proprietary technologies focus on lysins, which are highly selective enzymes derived from bacteriophages that can effectively burst and kill bacteria by targeting their outer cell walls. This specificity allows for customized bacterial targeting, reducing collateral damage to beneficial microorganisms and enhancing treatment precision. ArrowBiome’s proprietary platform technologies enable the engineering of lysins with desired properties, such as activity levels or broader bacterial killing spectrums. The company will use the June 2024 funding for the growth of its research and development.
Current Investors
Cocoon Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biotechnology, Molecular Science, Genetics & Gene Therapy
Website
www.arrowbiome.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
ArrowBiome Pte. Ltd. - financials
| Fiscal Year Ended | Mar 31, 2025 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.